| LLY | 9.71% | 771.71 | +1.34% | 6,409 | |
| NOVOb | 4.92% | 414.6 | -2.22% | 32,699 | |
| ABT | 4.41% | 123.67 | +2.62% | 17,321 | |
| AZN | 4.14% | 10,294.0 | -0.17% | 14,781 | |
Roche Holding AG ADR | - | 4.06% | - | - | 51,834 |
| UNH | 3.61% | 282.65 | -1.88% | 6,069 | |
BridgeBio Pharma Inc | - | 3.39% | - | - | 45,855 |
| BSX | 3.17% | 103.64 | -0.97% | 17,217 | |
| VRTX | 3.11% | 459.81 | -0.75% | 3,623 | |
| NOVN | 3.09% | 92.29 | -1.12% | 13,706 |
Tema ETF Trust - Tema Heart & Health ETF is an exchange traded fund launched and managed by Tema ETFs LLC. The fund is co-managed by NEOS Investment Management, LLC. It invests in public equity markets of global region. The fund invests in stocks of companies operating across health care, health care equipment and services, health care equipment and supplies, health care equipment, therapeutic devices, cardiovascular equipment, pharmaceuticals, biotechnology and life sciences, pharmaceutical products, cardiovascular drugs, products or services related to GLP-1 and the treatment of cardiovascular diseases and/or metabolic diseases sectors. The fund invests in growth stocks of companies across diversified market capitalization. It invests in stocks of companies that are deemed socially conscious in their business dealings and directly promote environmental responsibility. It employs fundamental and quantitative analysis with bottom-up and top-down stock picking approach to create its portfolio. The fund seeks to benchmark the performance of its portfolio against the S&P 500 Total Return Index. It employs internal and external research to create its portfolio. Tema ETF Trust - Tema Heart & Health ETF was formed on November 20, 2023 and is domiciled in the United States.